Albireo Pharma, Inc.
ALBONASDAQHealthcare
$44.15
+$0.00(+0.00%)
Market Cap$915887335
P/E Ratio—
52W High$45.23
52W Low$16.02
Albireo Pharma, Inc.（ALBO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ALBO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $40.58M | $8.31M | $9.64M | $12.74M | $0.00M |
| Cost of Revenue | $1.36M | $0.00M | $2.21M | $0.00M | $0.00M |
| Gross Profit | $39.22M | $8.31M | $7.43M | $12.74M | $0.00M |
| Gross Margin %(computed) | 96.66% | 100.00% | 77.07% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $82.52M | $76.78M | $45.58M | $31.73M | $12.99M |
| G&A Expenses | $0.00M | $42.45M | $22.96M | $18.06M | $15.25M |
| Total Operating Expenses | $162.71M | $104.58M | $70.75M | $50.63M | $24.58M |
| Operating Income | ($123.48M) | ($96.27M) | ($61.11M) | ($37.89M) | ($24.58M) |
| Operating Margin %(computed) | -304.31% | — | -634.21% | -297.41% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $13.93M | $11.36M | $5.30M | $0.00M | $0.04M |
| Income Before Tax | ($34.03M) | ($107.63M) | ($62.72M) | ($46.09M) | ($24.20M) |
| Income Tax Expense | $117.32M | $11.36M | $8.99M | $0.02M | $0.21M |
| Net Income | ($151.35M) | ($119.00M) | ($71.70M) | ($46.11M) | ($24.41M) |
| Net Margin %(computed) | -372.97% | — | -744.13% | -361.94% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-7.87 | $-7.45 | $-5.77 | $-3.94 | $-3.12 |
| Wtd Avg Shares | 19.22M | 15.98M | 12.44M | 11.70M | 7.82M |
| EBITDA | ($19.82M) | ($96.08M) | ($57.29M) | ($37.84M) | ($24.13M) |
| EBITDA Margin %(computed) | -48.85% | — | -594.58% | -297.06% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Albireo Pharma, Inc.
关于Albireo Pharma, Inc.（ALBO）损益表
Albireo Pharma, Inc.（ALBO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2021财年，ALBO实现营收$0.04B，毛利润$0.04B（毛利率96.66%），净利润($0.15B)（净利率-372.97%）。
常见问题
ALBO · 4 问Albireo Pharma, Inc.（ALBO）2021财年营收为$0.04B，同比up388.4%。
ALBO revenueALBO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09